Clinical Trial: Reconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma Surgery

U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06815705) titled 'Reconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma Surgery' on Dec. 23, 2024.

Brief Summary: Head and neck squamous cell carcinoma is one of the most common malignant tumors. At present, the standard treatment of head and neck squamous cell carcinoma recommended by the National Comprehensive Cancer Network(NCCN) treatment guideline in the United States and the Chinese Society of Clinical Oncology(CSCO) treatment guideline in China is a comprehensive treatment model based on surgery, supplemented by radiotherapy, chemotherapy, immunization and targeted therapy. Neck lymph dissection is one of the ...